Insilico Completes First-In-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969, Achieving First Clinical Milestone in Collaboration with Hygtia Therapeutics
Insilico Completes First-In-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969, Achieving First Clinical Milestone in Collaboration with Hygtia Therapeutics

Insilico Medicine (“Insilico”, HKEX: 3696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced it has achieved the first clinical milestone in its co-development collaboration with Hygtia Therapeutics with…

Hands Off: Why Human Touch Can Create a Food-Safety Blind Spot
Hands Off: Why Human Touch Can Create a Food-Safety Blind Spot

UMass Amherst researcher shows shoppers instinctively prefer hand-prepared foods despite potential food-safety risks Consumers often assume that hand-prepared foods are fresher, higher quality and safer than factory-packaged alternatives, but a new study co-authored by…

Strength Training Linked to Lower Heart Disease Risk in Women
Strength Training Linked to Lower Heart Disease Risk in Women

Women who consistently strength train showed substantially lower risk of major cardiovascular disease, particularly alongside aerobic activity and reduced sedentary time Women who lift weights may have a lower risk of major…

Birth Control Pills May Increase Binge Eating
Birth Control Pills May Increase Binge Eating

Why this matters: Researchers at Michigan State University found birth control pills may increase binge-eating symptoms for some women, underscoring the need for personalized approaches to care. The findings fill a major…